SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership [amend]
SEC Accession No. 0000899140-11-000512
Filing Date
2011-10-26
Accepted
2011-10-26 10:53:16
Documents
1
Filing Date Changed
2011-10-26
Group Members
CHARLES R. KAYEJOSEPH P. LANDYWARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 a102611.htm SC 13D/A 190255
  Complete submission text file 0000899140-11-000512.txt   192123
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Subject) CIK: 0001097264 (see all company filings)

IRS No.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60251 | Film No.: 111158226
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017
Business Address C/O WARBURG PINCUS LLC 450 LEXINGTON AVENUE NEW YORK NY 10017 212-878-0600
Warburg Pincus Private Equity VIII, L.P. (Filed by) CIK: 0001157334 (see all company filings)

IRS No.: 134161869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A